The post Sam Bankman-Fried’s ADHD Medication Problem During Trial appeared first on Coinpedia Fintech News
Sam Bankman-Fried, the former CEO of FTX, might take the stand in his ongoing criminal trial for fraud. However, a significant impediment stands in the way—Bankman-Fried’s inadequate access to prescribed ADHD medication, Adderall, while in federal custody. As stated in a recent letter to Judge Lewis Kaplan, the defense has expressed growing concern about his ability to concentrate and meaningfully participate in the trial.
Bankman-Fried’s defense attorney, Mark Cohen, made it clear in the letter that the lack of proper medication affects Bankman-Fried’s cognitive abilities as the trial moves closer to a decision-making point. It’s a pivotal moment in the case. If Bankman-Fried testifies and appears unfocused, the jury may interpret this as a sign of guilt, undermining the defense’s efforts.
Cohen highlighted the challenges in dealing with the Bureau of Prisons (BOP),
We współpracy z: https://coinpedia.org/news/sam-bankman-frieds-adhd-medication-problem-during-trial/
